Examination of individual longitudinal profiles (Supplementary Data, Supplementary Figure S1) showed CEA levels to be rising towards diagnosis only in cancer cases and to be relatively static in benign and non-cancer controls at each annual blood draw. This evidence concerns the gene CEACAM5 and cancer.